Pulmatrix, Inc. (PULM) Financials

PULM Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2024 11.5 million 590000
June 30, 2024 15.8 million 2.5 million
March 31, 2024 30.4 million 11.4 million
Dec. 31, 2023 34.0 million 16.0 million

PULM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2024 -3.1 million 197000
June 30, 2024 -3.9 million 103000
March 31, 2024 -2.9 million 198000
Dec. 31, 2023 -2.3 million 197000

PULM Net Income

No data available :(

PULM Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2024 10.8 million - -
June 30, 2024 13.8 million - 24000
March 31, 2024 16.3 million 8.2 million 8.6 million
Dec. 31, 2023 19.2 million 16.7 million 8.8 million

PULM Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2024 3.7 million
June 30, 2024 3.7 million
March 31, 2024 3.7 million
Dec. 31, 2023 3.7 million

PULM Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2024 - 814000 2.2 million -
June 30, 2024 244000 2.8 million 1.9 million -114000
March 31, 2024 154000 3.5 million 1.4 million -215000
Dec. 31, 2023 305000 3.5 million 741000 -170000

PULM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2024 366000 -
June 30, 2024 1.6 million 161000
March 31, 2024 5.9 million 274000
Dec. 31, 2023 2.2 million 208000

PULM Revenue by Segment
Graph available only for paid members. Upgrade to see it.

PULM

Price: $1.46

52 week price:
1.16
9.23

Earnings Per Share: -1.59 USD

P/E Ratio: -1.27

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 23200

Ebitda: -4.2 million

Market Capitalization: 4.7 million

Links: